In one five-year period, college athletes suffered more than 10,000 concussions — one-third of them while playing football. But an unusual team-up has recently brought a new, biomarker-based concussion test one step closer.
Barrow Neurological Institute is working with IBM’s Jeopardy-winning supercomputer, Watson, to identify treatment targets for Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis, or ALS.
ALS is a poorly understood neuromuscular disease with only limited treatment options. Its capacity to strike anyone, at any time, seemingly without pattern, has puzzled researchers.